Showing 1 - 20 results of 311 for search 'Ferrata Storti Foundation', query time: 0.05s Refine Results
  1. 1
    Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosis

    Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosis by Muhammad Umaid Rauf, Steven Law, Marisa Santostefano, Philip N. Hawkins, Aviva Petrie, Francesco Cappelli, Federico Perfetto, Yousuf Razvi, Aldostefano Porcari, Sriram Ravichandran, Adam Ioannou, Joshua Bomsztyk, Alessia Argirò, Costanza Gaudio, Elisabetta Antonioli, Alessandro Barilaro, Marco Delsante, Vittorio Di Maso, Maria G. Chiappini, Olabisi Ogunbiyi, Oliver C. Cohen, Ana Martinez-Naharro, Carol Whelan, Helen J. Lachmann, Ashutosh D. Wechalekar, Federico Alberici, Marianna Fontana, Marco Allinovi, Julian D. Gillmore

    Published 2025-06-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report

    Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report by Pedro Henrique Prata, Dirk-Jan Eikema, Brian Piepenbroek, Austin Kulasekararaj, Beatrice Drexler, Jennifer M-L. Tjon, Krista Vaht, Mahmoud Aljurf, Patrice Chevallier, Tobias Gedde-Dahl, Ain Kaare, Urpu Salmenniemi, Thomas Schroeder, Jenny Byrne, Jérôme Cornillon, Fiorenza Barraco, Johan Maertens, Eleni Tholouli, Uwe Platzbecker, Nicolaus Kröger, Didier Blaise, Simona Sica, Robert Zeiser, Antonio Maria Risitano, Régis Peffault de Latour, EBMT Severe Aplastic Anemia Working Party

    Published 2025-07-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    “Dexamethasing” acute myeloid leukemia: new opportunities for an “old” drug

    “Dexamethasing” acute myeloid leukemia: new opportunities for an “old” drug by Jesús Duque-Afonso, Julian List, Michael Lübbert

    Published 2025-05-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    After CAR-T therapy for myeloma: challenge of persistent cytopenias and infections

    After CAR-T therapy for myeloma: challenge of persistent cytopenias and infections by Ofrat Beyar-Katz, Anat Stern

    Published 2025-08-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes

    Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes by Marlise R. Luskin, Jessica T. Leonard

    Published 2025-06-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome

    Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outc... by Serena De Matteis, Laura Del Coco, Federica De Castro, Anna Maria Giudetti, Beatrice Casadei, Francesco Iannotta, Francesco De Felice, Enrica Tomassini, Francesca Vaglio, Maria Naddeo, Irene Salamon, Gianluca Storci, Noemi Laprovitera, Daria Messelodi, Salvatore Nicola Bertuccio, Marta Tassoni, Barbara Sinigaglia, Francesco Barbato, Margherita Ursi, Elena Campanini, Enrico Maffini, Marcello Roberto, Cinzia Pellegrini, Elisa Dan, Chiara Pirazzini, Paolo Garagnani, Manuela Ferracin, Pier Luigi Zinzani, Francesco Paolo Fanizzi, Massimiliano Bonafè, Francesca Bonifazi

    Published 2024-12-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance

    Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance by Christian Schmidt, Gabriel Scheubeck, Vindi Jurinovic, Martin Sökler, Roswitha Forstpointner, Christian Buske, Andreas Viardot, Ulrich Keller, Ullrich Graeven, Reinhard Marks, Mathias Hänel, Rüdiger Liersch, Jan Dürig, Christiane Pott, Eva Hoster, Michael Unterhalt, Wolfgang Hiddemann

    Published 2025-06-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia

    Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia by Bradley Rockwell, Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, Yogen Saunthararajah, Kira Gritsman, Alejandro R. Sica, Noah Kornblum, Nishi Shah, David Levitz, Lauren C. Shapiro, Ridhi Gupta, Anne Munoz, Aradhika Dhawan, Karen Fehn, Monica Comas, Jhannine Verceles, Dennis L. Cooper, Marina Konopleva, Eric J. Feldman, Amit Verma

    Published 2025-07-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV study

    Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV s... by Muhit Özcan, Ryan D. Cassaday, Ewa Zarzycka, Erik Vandendries, Fan Zhang, Ying Chen, Alejandra Nieto, Fatih Demirkan, Pau Montesinos, Fevzi Altuntas

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Cytogenetic abnormalities in polycythemia vera: phenotypic correlates and prognostic relevance in 669 informative cases

    Cytogenetic abnormalities in polycythemia vera: phenotypic correlates and prognostic relevance in 669 informative cases by Moazah Iftikhar, Masooma Rana, Yamna Jadoon, Maymona Abdelmagid, Kaaren Reichard, Cinthya Zepeda Mendoza, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat

    Published 2025-03-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial

    Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial by Salomon Manier, Meletios-Athanasios Dimopoulos, Xavier P. Leleu, Philippe Moreau, Michele Cavo, Hartmut Goldschmidt, Robert Z. Orlowski, Muriel Tron, Christina Tekle, Marie-France Brégeault, Andrea T. Shafer, Meral Beksac, Thierry Facon

    Published 2025-03-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up

    Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up by Andrew J. Portuguese, Jennifer J. Huang, Yein Jeon, Mahnoosh Taheri, Aya Albittar, Emily C. Liang, Alexandre V. Hirayama, Erik L. Kimble, Lorenzo Iovino, Christina Poh, Ajay K. Gopal, Mazyar Shadman, Brian G. Till, Filippo Milano, Aude G. Chapuis, Folashade Otegbeye, Ryan D. Cassaday, Ryan S. Basom, Qian Vicky Wu, David G. Maloney, Jordan Gauthier

    Published 2025-03-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies

    Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a st... by Qian Yan, Jinlin Liu

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Enforcement of stem-cell dormancy by nucleophosmin mutation is a critical determinant of unrestricted self-renewal during myeloid leukemogenesis

    Enforcement of stem-cell dormancy by nucleophosmin mutation is a critical determinant of unrestricted self-renewal during myeloid leukemogenesis by Maria Elena Boggio Merlo, Maria Mallardo, Lucilla Luzi, Giulia De Conti, Chiara Caprioli, Roman Hillje, Mario Faretta, Cecilia Restelli, Andrea Polazzi, Valentina Tabanelli, Angelica Calleri, Stefano Pileri, Pier Giuseppe Pelicci, Emanuela Colombo

    Published 2025-03-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Von Willebrand Disease and Angiodysplasia: a wider view of pathogenesis in pursuit of therapy

    Von Willebrand Disease and Angiodysplasia: a wider view of pathogenesis in pursuit of therapy by Christina Crossette-Thambiah, Anna M. Randi, Michael Laffan

    Published 2024-11-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Treatment approaches and clinical outcomes in primary colorectal MALT lymphoma: a single institution retrospective study of 66 patients

    Treatment approaches and clinical outcomes in primary colorectal MALT lymphoma: a single institution retrospective study of 66 patients by Suheil Albert Atallah-Yunes, Matthew J. Rees, Thomas M. Habermann, Yucai Wang, Javier Munoz, Madiha Iqbal, Jose C. Villasboas, Ellen D. McPhail, Thomas E. Witzig, Stephen M. Ansell, Grzegorz S. Nowakowski

    Published 2025-06-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

    Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative n... by Ali Alsugair, Saubia Fathima, Fnu Aperna, Naseema Gangat, Ayalew Tefferi

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Leukemia stem cells in acute myeloid leukemia-mimicking “space and time continuum”?

    Leukemia stem cells in acute myeloid leukemia-mimicking “space and time continuum”? by Adriana Plesa, Christophe Roumier

    Published 2025-07-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Trends in mortality rate after cancer-related thrombosis give hope for the future

    Trends in mortality rate after cancer-related thrombosis give hope for the future by Bengt Zöller

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes

    PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes by Alexandre Bazinet, Alex Bataller, Guillermo Montalban-Bravo, Kelly Chien, Koji Sasaki, Wei Ying Jen, Mahesh Swaminathan, Tapan Kadia, Courtney DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, Hagop Kantarjian

    Published 2025-07-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: